| abstract |
Antimycotic compositions are produced which comprise an antimycotically effective amount of a 1,2,4-triazole of the formula: <IMAGE> or a pharmaceutically acceptable non-toxic salt thereof wherein X1 is hydrogen or alkyl; X2 is hydrogen or alkyl; R1 is alkyl, unsubstituted or substituted aryl or unsubstituted or substituted aralkyl; R2 is hydrogen, alkyl or unsubstituted or substituted aryl; R3 is alkyl, cycloalkyl, unsubstituted or substituted aryl or unsubstituted or substituted aralkyl; and Y is a keto group or a functional derivative of a keto group, in combination with a pharmaceutically acceptable non-toxic, inert diluent or carrier. |